Gilead Sciences Files 8-K on Shareholder Votes and Exhibits

Ticker: GILD · Form: 8-K · Filed: May 8, 2025 · CIK: 882095

Gilead Sciences, INC. 8-K Filing Summary
FieldDetail
CompanyGilead Sciences, INC. (GILD)
Form Type8-K
Filed DateMay 8, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, financial-reporting, sec-filing

Related Tickers: GILD

TL;DR

Gilead filed an 8-K on May 8th covering shareholder votes and financial exhibits.

AI Summary

Gilead Sciences, Inc. filed an 8-K on May 8, 2025, reporting on matters submitted to a vote of security holders and financial statements/exhibits as of May 7, 2025. The filing details their principal executive offices located at 333 Lakeside Drive, Foster City, California, 94404.

Why It Matters

This filing provides updates on corporate governance and financial reporting for Gilead Sciences, which is crucial for investors to understand the company's operational and shareholder-related activities.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of corporate actions and financial information, not indicating any immediate operational or financial distress.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Gilead Sciences?

The primary purpose is to report on matters submitted to a vote of security holders and to file financial statements and exhibits as of May 7, 2025.

When was this 8-K report filed?

The report was filed on May 8, 2025.

Where are Gilead Sciences' principal executive offices located?

Gilead Sciences' principal executive offices are located at 333 Lakeside Drive, Foster City, California, 94404.

What is the state of incorporation for Gilead Sciences?

Gilead Sciences is incorporated in Delaware.

What is the IRS Employer Identification Number for Gilead Sciences?

The IRS Employer Identification Number for Gilead Sciences is 94-3047598.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding GILEAD SCIENCES, INC. (GILD).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing